Seagen Inc. is a global biotechnology company that discovers, develops, and commercializes medicines for cancer. The company has a pipeline of therapies at various stages of preclinical testing, clinical testing, and development. For more information visit www.seagen.com.
Contact:
Lauren Whillock (ADCETRIS)
E-mail - lwhillock@seagen.com
Adam Miller (PADCEV)
E-mail - amiller@seagen.com
Christian Tyrrell (TUKYSA)
E-mail - ctyrrell@seagen.com
ADCETRIS
ADCETRIS (brentuximab vedotin) for injection Prescribing Information, including BOXED WARNING »
ADCETRIS 5-Year ECHELON-1 Update »
PADCEV
PADCEV (enfortumab vedotin-ejfv) Prescribing Info »
TUKYSA
TUKYSA (tucatinib) tablets US Prescribing Information »
